| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.005 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.34 | 0.005 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |